Stock Analiz

Novartis AG (NVS) stock forecast and price target

Price $160.50 · data as of November 13, 2026

12-month price target

Average target$157.10
Upside / downside−2.1%
Analysts10
ConsensusHold
Low $130.00Average $157.10High $185.00

Gold marker: average target · white marker: today’s price ($160.50)

Analyst ratings

Strong buy 3Buy 2Hold 4Sell 1Strong sell 1

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$9.07+1.0%$57.8B
Next fiscal year
ends December 31, 2027
$9.93+9.5%$61.7B
Next quarter
ends December 31, 2026
$2.23+9.9%$14.8B
Quarter after
ends March 31, 2027
$2.27+14.1%$14.3B

Consensus of the analysts covering Novartis, updated daily. In the last 30 days 4 estimates were raised and 0 lowered.

Our model vs. Wall Street

Analysts see 2.1% downside over 12 months. Our discounted cash flow model with moderate assumptions puts Novartis’s intrinsic value about 9% below today’s market value, and it scores 2.0 out of 5 on our checks. Price targets follow sentiment; a DCF follows cash. When both point the same way the signal is stronger. Try your own assumptions.

Frequently asked questions

What is the Novartis stock price target?

The average 12-month target from 10 analysts is $157.10, 2.1% below the current price of $160.50 Targets range from $130.00 to $185.00.

Is Novartis a buy according to analysts?

The consensus rating is “Hold” (3 strong buy, 2 buy, 4 hold, 1 sell, 1 strong sell). Ratings are opinions, not guarantees; this is not investment advice.

How much is Novartis expected to earn?

Analysts expect EPS of $9.07 for the fiscal year ending December 31, 2026 and $9.93 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.